Successful Treatment With Infliximab in a Patient With Diffuse Subretinal Fibrosis Syndrome

American Journal of Ophthalmology

Volumn 143, Issue 3, 2007, Pages 533-534

  Adán, Alfredo ^a   Sanmartí, Raimon ^a   Burés, Anniken ^a   Casaroli Marano, Ricardo P ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; INFLIXIMAB; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLURRED VISION; CASE REPORT; CHOROIDITIS; DIFFUSE SUBRETINAL FIBROSIS SYNDROME; FIBROSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; RETINA DISEASE; SCOTOMA; VISUAL ACUITY;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CHOROIDITIS; FIBROSIS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; RETINA; RETINAL DISEASES; SPONDYLARTHROPATHIES; SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847015616     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.10.047     Document Type: Article

References (7)

1. Palestine A.G., Nussenblatt R.B., Parver L.M., and Knox D.L. Progressive subretinal fibrosis and uveitis. Br J Ophthalmol 68 (1984) 667-673
2. Cantrill H.L., and Folk J.C. Multifocal choroiditis associated with progressive subretinal fibrosis. Am J Ophthalmol 101 (1986) 170-180
3. Zeidler H., Mau W., and Khan M.A. Undifferentiated spondyloarthropathies. Rheum Dis Clin North Am 18 (1992) 187-202
4. Linder R., Hoffmann A., and Brunner R. Prevalence of the spondyloarthritides in patients with uveitis. J Rheumatol 31 (2004) 2226-2229
5. Brandt J., Haibel H., Reddig J., et al. Successful short-term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-α monoclonal antibody infliximab. J Rheumatol 29 (2002) 118-122
6. Sfikakis P.P., Theodossiadis P.G., Katsiari C.G., et al. Effect of infliximab on sight-threatening panuveitis in Behçet′s disease. Lancet 358 (2001) 295-296
7. Lindstedt E.W., Baarsma G.S., Kuijpers R.W., and van Hagen P.M. Anti-TNF-α therapy for sight threatening uveitis. Br J Ophthalmol 89 (2005) 533-536